Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
DNA
#2983
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
6.9
8
USD
-0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.99%
Monthly Change
-10.40%
6 month change
+6.48%
Year Change
-21.40%
Previous Close
7.2
7
Open
6.9
4
Low
6.9
2
High
6.9
9
Volume
586
Markets
US Stock Market
Healthcare
Biotechnology
DNA
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
27.01 M
39.25 M
41.27 M
45.81 M
49.94 M
67.34 M
Valuation ratios
Enterprise value
10.74 B
1.77 B
2.45 B
-21.14 M
322.46 M
388.04 M
Price to earnings ratio
-5.98
-1.26
-3.63
-0.93
-1.47
-1.47
Price to sales ratio
34.95
5.56
12.91
2.24
2.71
3.39
Price to cash flow ratio
-44.54
-10.52
-10.99
-1.59
-2.69
-2.51
Price to book ratio
7.51
1.53
0.28
0.04
0.91
0.22
Enterprise value to EBITDA ratio
-5.93
-0.82
-3.09
0.04
-1.22
-1.57
Profitability ratios
Return on assets %
-0.88
-0.83
-0.54
-0.4
-0.28
-0.05
Return on equity %
-1.17
-1.21
-0.81
-0.76
-0.61
-0.11
Return on invested capital %
-1 742.21
-1 127.28
-361.88
-276.06
-174.95
-26.54
Gross margin %
100
100
100
100
94.89
92.65
Operating margin %
-601.11
-462.41
-343.76
-246.54
-185.29
-250.33
EBITDA margin %
-595.05
-451.83
-315.31
-218.51
-155.31
-218.98
Net margin %
-601.63
-440.63
-355.08
-240.94
-183.81
-199.72
Liquidity ratios
Quick ratio
12.76
8.36
6.11
—
—
—
Current ratio
12.79
8.38
6.11
5.62
4.92
4.57
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.15
0.21
0.12
0.15
0.15
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-7.46
-6.01
-6.08
-6.16
-3.08
-2.92
EBIT per share
-53.48
-52.6
-17.78
-10.79
-5.84
-4.82
EBITDA per share
-53.22
-51.4
-16.31
-9.56
-4.77
-4.26
Total debt per share
—
—
—
—
—
—
Cash per share
45.58
31.33
19.42
10.82
7.62
1.36
Net current asset value per share
50.66
34.53
20.61
11.61
8.51
5.36
Tangible book value per share
44.26
41.34
19.97
12.4
8.14
6.05
Working capital per share
46.7
30.41
17.24
9.55
6.78
4.18
Book value per share
44.26
41.34
22.69
13.8
9.17
6.77
News
Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2026 Earnings Call Transcript
Ginkgo Bioworks: Another Lost Year (NYSE:DNA)
Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2026 Earnings Call Transcript
Ginkgo Bioworks: Shedding Biosecurity And Doubling Down On Autonomy (NYSE:DNA)
BTIG cuts Ginkgo Bioworks stock price target on autonomous lab shift
Ginkgo Bioworks launches cloud-based autonomous lab platform
Ginkgo Bioworks Makes Major Pivot (NYSE:DNA)
Ginkgo Bioworks Holdings, Inc. (DNA) Q4 2025 Earnings Call Transcript
Netflix, Dell among market cap stock movers on Friday
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter - Ginkgo Bioworks Holdings (NYSE:DNA)
Ginkgo Bioworks, Invaio Sciences partner on peptide crop protection
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts